Pharmaceuticals and Medical Devices Agency This English version is intended to be a reference material to provide convenience for users. In the event of inconsistency between the Japanese original and this English transl

Source URL: www.pmda.go.jp

• Hypertension
• Blood pressure
• Cerebrovascular diseases
• Neurotrauma
• Sofosbuvir
• Cerebral hemorrhage

This is an electronically controlled document. User is responsible to verify and use the current revision. GENERAL CONFORMITY CERTIFICATE Pursuant to 15 U.S.C. § 2063(a), Gilead Sciences, Inc. certifies that based on a

Source URL: www.gilead.com

• Specialty drugs
• Gilead Sciences
• Breakthrough therapy
• Gilead
• Sofosbuvir

State of Illinois Illinois Department of Public Health Ryan White Part B ADAP Medication Assistance Program (MAP) Application for Pre Approval of Hepatitis C Medication Assistance The following medications are n o w avai

Source URL: hivcareconnect.com

• Breakthrough therapy
• Gilead Sciences
• Healthcare-associated infections
• Carbamates
• Cyclopropanes
• Ledipasvir/sofosbuvir
• Sofosbuvir
• Ombitasvir/paritaprevir/ritonavir
• Hepatitis C
• Daclatasvir
• Ribavirin
• Hepatitis

TF_AITemplate_210x280_RZ.indd

Source URL: www.pcsg.org.uk

• Hepatology
• Infectious causes of cancer
• RTT
• Healthcare-associated infections
• Viral diseases
• Hepatitis C
• Hepatitis
• Liver cancer
• Sofosbuvir
• Cirrhosis
• Liver disease
• Simeprevir

Pharmaceuticals and Medical Devices Agency This English version is intended to be a reference material for the convenience of users. In the event of inconsistency between the Japanese original and this English translatio

Source URL: www.pmda.go.jp

• Breakthrough therapy
• Gilead Sciences
• Specialty drugs
• Cyclopropanes
• Healthcare-associated infections
• Sofosbuvir
• Ledipasvir
• Hepatitis C
• Interferon
• Peginterferon alfa-2a
• Hepatitis
• Cirrhosis

PDF Document

Source URL: www.hepcoalition.org

• Pharmacology
• Pharmaceutical sciences
• Specialty drugs
• Chemistry
• Breakthrough therapy
• Gilead Sciences
• Organofluorides
• Propionates
• Sofosbuvir
• Ledipasvir
• Hepatitis C
• Prescription costs

SPECIAL AUTHORIZATION REQUEST FORM The Newfoundland and Labrador Prescription Drug Program (NLPDP) Request for Coverage of Harvoni®, Solvadi® and Ibavyr® Pharmaceutical Services Department of Health and Community Serv

Source URL: www.health.gov.nl.ca

• Medicine
• Chemistry
• Clinical medicine
• Breakthrough therapy
• Gilead Sciences
• Cyclopropanes
• Healthcare-associated infections
• Carbamates
• Sofosbuvir
• Ledipasvir
• Hepatitis C
• Interferon

0000000000000000002179008

Source URL: www.gilead.com

• Gilead Sciences
• Specialty drugs
• Breakthrough therapy
• Ledipasvir/sofosbuvir
• Cyclopropanes
• Sofosbuvir
• Ledipasvir
• Gilead

ruim duizend hiv-mannen kunnen erdoor genezen van de co-infectie hepatitis c, maar toch krijgen zij het medicijn sofosbuvir niet vergoed. winq | gk sprak met teleurgestelde artsen, belangenorganisaties en patiënten.

Source URL: www.maartendallinga.nl

NLT-gruppens yttrande till landstingen gällande nya läkemedel vid kronisk hepatit C: simeprevir (Olysio) sofosbuvir (Sovaldi) och daclatasvir (Daklinza) samt kommentar kring ledipasvir/sofosbuvir (Harvoni)

Source URL: www.janusinfo.se